| Financial Year |
March 31 2023 |
| Monetary Funds |
4,369,113,592.98 |
| Held-for-trading Financial Assets |
59,267,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,043,099,512.18 |
| Advances to Suppliers |
206,312,478.61 |
| Other Receivables |
402,852,342.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,246,576,980.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
188,912,672.30 |
| Total Current Assets |
10,524,523,196.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,796.95 |
| Investment Properties |
-- |
| Fixed Assetes |
1,473,834,777.82 |
| Under-construction Projects |
1,098,338,014.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
628,108,732.21 |
| R&D expenses |
71,764,127.90 |
| Goodwill |
2,592,585,969.68 |
| Long-Term Deferred and Prepaid Expenses |
581,760,817.34 |
| Deferred Income Tax Assets |
184,807,698.23 |
| Other Non-Current Assets |
286,052,150.95 |
| Sub-Total of Non-Current Assets |
10,630,842,540.11 |
| Total Assets |
21,155,365,736.59 |
| Short-Term Loans |
692,240,673.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,606,936,666.70 |
| Accounts Payable |
2,533,283,705.71 |
| Accounts Received In Advance |
411,408.54 |
| Employee Compensation Payable |
205,109,937.18 |
| Taxes Payable |
329,663,531.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
586,095,923.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
998,531,595.14 |
| Other Current Liabilities |
27,123,099.82 |
| Sub-Total of Current Liabilities |
9,334,344,611.44 |
| Long-term Loans |
186,084,821.00 |
| Bonds Payable |
1,305,427,001.80 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
327,535.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,237,031,157.37 |
| Total Liabilities |
13,571,375,768.81 |
| Paid-In Capital(Or Share Stock) |
949,085,014.00 |
| Capital Surplus |
1,540,721,611.13 |
| Surplus Reserve |
392,746,270.71 |
| LESS:Treasury Stock |
35,706,888.50 |
| Undistributed Profits |
3,676,870,621.03 |
| Minority Stockholder's Interest |
870,337,537.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,713,652,430.64 |
| Owner's Equity（Stockholder's Equity） |
7,583,989,967.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,155,365,736.59 |
